Phenotyping Diabetes Mellitus on Aggregated Electronic Health Records from Disparate Health Systems

نویسندگان

چکیده

Background: Identifying patients with diabetes mellitus (DM) is often performed in epidemiological studies using electronic health records (EHR), but currently available algorithms have features that limit their generalizability. Methods: We developed a rule-based algorithm to determine DM status the nationally aggregated EHR database. The was validated on two chart-reviewed samples (n = 2813) of (a) atrial fibrillation (AF, n 1194) and (b) randomly sampled hospitalized 1619). Results: diagnosis codes alone resulted sensitivity 77.0% 83.4% AF random samples, respectively. proposed combines blood glucose values medication usage diagnostic exhibits sensitivities between 96.9% 98.0%, while positive predictive (PPV) ranged 61.1% 75.6%. Performances were comparable across sexes, lower specificity observed younger (below 65 versus above) both validation (75.8% vs. 90.8% 60.6% 88.8%). robust for missing laboratory data not data. Conclusions: In this nationwide database analysis, an identifying has been validated. supports quantitative bias analyses future involving EHR-based studies.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Next-generation phenotyping of electronic health records

The national adoption of electronic health records (EHR) promises to make an unprecedented amount of data available for clinical research, but the data are complex, inaccurate, and frequently missing, and the record reflects complex processes aside from the patient's physiological state. We believe that the path forward requires studying the EHR as an object of interest in itself, and that new ...

متن کامل

High Throughput Phenotyping for Dimensional Psychopathology in Electronic Health Records

BACKGROUND Relying on diagnostic categories of neuropsychiatric illness obscures the complexity of these disorders. Capturing multiple dimensional measures of neuropathology could facilitate the clinical and neurobiological investigation of cognitive and behavioral phenotypes. METHODS We developed a natural language processing-based approach to extract five symptom dimensions, based on the Na...

متن کامل

Electronic health records-driven phenotyping: challenges, recent advances, and perspectives.

With the completion of the Human Genome Project as well as recent advances in genomic science and comparative biological studies, a new era of individualized medicine is evolving where novel biomedical discoveries are leading to more effective prevention, treatment, and diagnosis of disease. Although altered phenotypes are one of the most reliable manifestations of altered gene functions, resea...

متن کامل

Privacy Controls for Electronic Health Records Systems

The federal push to have the US healthcare system completely electronic in the next decade raises significiant challenges to Information Technology professionals tasked with the job of implementing these systems and ensuring that they work properly. The obvious technical issues of storage medium representation and optimisation, appropriate security models and systems interoperability will event...

متن کامل

Combining billing codes, clinical notes, and medications from electronic health records provides superior phenotyping performance

OBJECTIVE To evaluate the phenotyping performance of three major electronic health record (EHR) components: International Classification of Disease (ICD) diagnosis codes, primary notes, and specific medications. MATERIALS AND METHODS We conducted the evaluation using de-identified Vanderbilt EHR data. We preselected ten diseases: atrial fibrillation, Alzheimer's disease, breast cancer, gout, ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Pharmacoepidemiology

سال: 2023

ISSN: ['2813-0618']

DOI: https://doi.org/10.3390/pharma2030019